Secchi, O.; Franchi, A.; Lunello, A. Comments to “Cost Per Responder for Vedolizumab and Ustekinumab in Crohn’s Disease Patients After Failure of TNF-α Inhibitors in Italy.” AboutOpen 2023, 10, 82-86.